Ultram and Retinal ischaemia - a phase IV clinical study of FDA data

Summary:

Retinal ischaemia is reported as a side effect among people who take Ultram (tramadol hydrochloride), especially for people who are female, 50-59 old, also take Vioxx, and have Joint pain.

The phase IV clinical study analyzes which people have Retinal ischaemia when taking Ultram. It is created by eHealthMe based on reports of 26,802 people who have side effects when taking Ultram from the FDA, and is updated regularly.

What is Ultram?

Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 28,425 Ultram users. Check the latest studies of Ultram.

What is Retinal ischaemia?

Retinal ischaemia (lack of blood supply to retina) is found to be associated with 107 drugs and 189 conditions by eHealthMe. Check the latest studies of Retinal ischaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

26,802 people reported to have side effects when taking Ultram.
Among them, 12 people (0.04%) have Retinal ischaemia.

Among these 12 people:

What is the gender of people who have Retinal ischaemia when taking Ultram? *

female: 100 %
male: 0.0 %

What is the age of people who have Retinal ischaemia when taking Ultram? *

What are other drugs people take besides Ultram? *

Neurontin: 11 people, 91.67%
Serzone: 11 people, 91.67%
Zanaflex: 11 people, 91.67%
Vioxx: 11 people, 91.67%
Klonopin: 1 person, 8.33%
Gaviscon: 1 person, 8.33%
Glycolax: 1 person, 8.33%
Heparin: 1 person, 8.33%
Humulin R: 1 person, 8.33%
Hydrocodone Bitartrate And Acetaminophen: 1 person, 8.33%

What are other side effects people have besides Retinal ischaemia? *

Visual Acuity Reduced (reduced clearness of vision): 12 people, 100.00%
Drug Hypersensitivity: 12 people, 100.00%
High Blood Pressure: 12 people, 100.00%
Haemorrhage Intracranial (bleeding within the skull): 11 people, 91.67%
Hypoaesthesia (reduced sense of touch or sensation): 11 people, 91.67%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 11 people, 91.67%
Acute Myocardial Infarction (acute heart attack): 11 people, 91.67%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 11 people, 91.67%
Sleep Apnea Syndrome: 11 people, 91.67%
Fall: 11 people, 91.67%

What are the existing conditions these people have? *

Joint Pain: 7 people, 58.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 33.33%
Pulmonary Congestion (congestion in the lungs): 1 person, 8.33%
Impaired Gastric Emptying: 1 person, 8.33%
Cough: 1 person, 8.33%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ultram and have Retinal ischaemia?

- Check whether Retinal ischaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ultram:

Ultram (28,425 reports)

Browse all side effects of Ultram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinal ischaemia:

Retinal ischaemia (107 drugs)

Browse all the conditions that are associated with Retinal ischaemia:

Retinal ischaemia (189 conditions)

Related publications that referenced our studies

Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on tramadol hydrochloride (the active ingredients of Ultram) and Ultram (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.